Search Results 541-550 of 11760 for Ginseng

  1. Gemifloxacin (oral route) - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  2. News - Veena Taneja, Ph.D. - Mayo Clinic

    Veena Taneja, Ph.D. · News · Don't miss your chance! · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers · International Patients.

  3. Add antioxidants to your diet - Mayo Clinic

    Antioxidants are certain nutrients, such as vitamins C or E, or carotenoids, which may help protect cells against daily damage. As cells do their job, ...

  4. Creation of a Diverse Ancestry Biobank - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. A pivotal study of derazantinib in patients with inoperable or advanced intrahepatic cholangiocarcinoma and FGFR2 gene fusions or FGFR2 gene mutations or amplifications - Mayo Clinic

    1 in subjects with inoperable or advanced intrahepatic cholangiocarcinoma (iCCA) whose tumors harbor FGFR2 gene fusions (by FISH performed by the central ...

  6. Mayo Clinic

    rectal-cancer-fl · Don't miss your chance! · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers · International Patients · Charitable Care ...

  7. Drugs and Supplements

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “N.html.html.html.html” to learn about drug side ...

  8. Mayo Clinic

    YouTube-Pulmonary Tests PFT Chest CT Flexible Bronchoscopy · More videos on YouTube · Fund research. Save lives. · About Mayo Clinic · Medical Professionals.

  9. Rezafungin (intravenous route) - Mayo Clinic

    Rezafungin injection is used to treat candidemia (fungal infection in the blood) and invasive candidiasis in patients who have limited or no other treatment ...

  10. TIGER-2: A Phase 2, Open-label, Multicenter, Safety and Efficacy Study of Oral CO-1686 as 2nd Line EGFR-directed TKI in Patients With Mutant EGFR Non-small Cell Lung Cancer (NSCLC) - Mayo Clinic

    TIGER-2: A Phase 2, Open-label, Multicenter, Safety and Efficacy Study of Oral CO-1686 as 2nd Line EGFR-directed TKI in Patients With Mutant EGFR Non-small Cell ...